OrbiMed Advisors LLC's Form 4 filing
Alpine Immune Sciences, Inc. (ALPN) · filed Sep 21, 2021
- Accession no.
- 0000947871-21-001010
- Filed
- Sep 21, 2021, 6:42 PM ET
- Trade date
- Sep 17, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $9.50M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | PPurchaseAcquired | +585,106 | $9.40F1 | +$5,499,996.4 | 3,656,061 | Indirect | Duplicate filing |
| Sep 17, 2021 | Common Stock | PPurchaseAcquired | +425,531 | $9.40F1 | +$3,999,991.4 | 425,531 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock were purchased in a block order at a price of $9.40.
Referenced by the price of 2 transactions in Table I.